pronounce semaglutide How To (Correctly) The Weight-Loss Drug Revolution—From Shots
Description
Hazard of 5%, 10%, and 15% Weight Loss Among the matched population at risk (undergoing treatment), 81.8% (95% CI, 79.8%-83.7%) receiving tirzepatide vs 66.5% (95% CI, 64.3%-68.7%) receiving semaglutide achieved 5% or greater weight loss, 62.1% (95% CI, 59.7%-64.3%) vs 37.1% (95% CI, 34.6%-39.4%) achieved 10% or greater weight loss, and 42.3% (95% CI, 39.8%-44.6%) vs 18.1% (95% CI, 16.1%-20.0%) achieved 15% or greater weight loss within 365 days (Figure 2)
There is no universal best for every individual but from a receptor-complexity perspective, triple agonists currently represent the most advanced metabolic approach under investigation
Structural Basis for GLP-1 Receptor Activation by LY3502970, an Orally Active Nonpeptide Agonist
For patients, waiting means confidence that the drug is safe for years of use
On physical exam, she had mild abdominal distension and tenderness in the epigastric area
